Charity Commission Registration No. 286363
THE BRITISH NEUROPATHOLOGICAL SOCIETY
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2025
British Neuropathological Society- President’s Report 2025
During 2025, the British Neuropathological Society continued to advance its charitable aims through scientific meetings, education, professional support and international collaboration.
The 126th Annual Meeting of the British Neuropathological Society was held from 29 to 31 January 2025 at The View, Royal College of Surgeons of England, London. The meeting opened with a symposium on spatial transcriptomics, bringing together internationally recognised speakers (Prof Schirmer, Heidelberg, Germany; Dr Bayraktar, Cambridge, UK; Prof Duff, UCL, UK; Prof Heiland, Erlangen, Germany; Dr Watson, Oxford, UK and Prof Gerstung, DKFZ, Germany) to discuss the use of spatial and high-dimensional technologies in inflammatory disease, neurodegeneration and brain tumours. Professor David Ellison of St Jude Children’s Research Hospital, USA, delivered the Alfred Meyer Memorial Lecture on “The challenges of classifying brain tumors”. The Thursday and Friday scientific programme covered brain tumours, neurodegeneration, and a broad range of topics in experimental and diagnostic neuropathology. It included platform presentations, flash talks and poster discussions, as well as the Society’s Professional Affairs and Business Meetings. The final day featured a Clinical Update Session on epilepsy pathology, followed by case reports and the Diagnostic Slide Session, which incorporated the External Quality Assurance Scheme. The meeting concluded with the announcement of prizes.
The Society continued to support networking and engagement among the next generation of neuropathologists and neuroscientists. A BNS Next Generation Social was held at the Gordon Museum of Pathology immediately before the Annual Meeting. The Society contributed a donation towards the Museum’s upkeep.
Continuing education through meetings, symposia and training remains central to the Society’s charitable purpose. Its residential Summer School is held every two years at the Royal Agricultural College in Cirencester. The 2025 Summer School, “Brain Tumour Diagnostics: Decoding Principles and Controversies”, examined the growing integration of histopathology, molecular testing and emerging technologies in diagnostic neuropathology. The programme explored novel tumour entities, artificial intelligence and digital pathology, while interactive case-based sessions allowed participants to apply these principles in practice.
The trustees remain committed to broadening participation in meetings and forums relevant to clinical neuropathology and applied neurobiology, particularly for trainees, early-career scientists and others at an early stage of their careers. The Society continued its bursary and small-grant schemes to support research, education and attendance at scientific meetings. It also purchased four places for clinical trainees on Euro-CNS training courses and supported other educational activities, including initiatives organised by the Royal College of Pathologists.
The Society supports the International Society of Neuropathology and Euro-CNS through annual percapita membership subscriptions, enabling BNS members to take part in their activities and educational programmes and access their publications. It has also committed substantial financial support to the European Congress of Neuropathology 2027 to be held in Edinburgh reflecting its commitment to supporting international neuropathology and showcasing UK neuropathology on the global stage.
Royalties from Neuropathology and Applied Neurobiology , published by Wiley on the Society’s behalf, remain a major source of annual income. As a charity, the BNS is governed by trustees comprising the President, Vice-President, Honorary Secretary and Treasurer. They are responsible for ensuring that the Society delivers clear charitable benefit while maintaining sustainable finances. Membership subscriptions for consultants and members holding substantive appointments were increased to reflect the rising cost of member benefits and charitable activities.
The Society continues to support diagnostic neuropathology as a GMC-recognised independent medical specialty through work on recruitment, curriculum development, training and assessment. It also funds and supports its fully digitised External Quality Assurance Scheme. High participation and continuous professional review help maintain diagnostic standards and public confidence in the national neuropathology service.
Professor Silvia Marino, MD FRCPath
THE BRITISH NEUROPATHOLOGICAL SOCIETY
LEGAL AND ADMISTRATIVE INFORMATION
Trustees Dr Silvia Marino (President) Dr Kathreena Kurian (Vice President) Dr Karl Frontzek (Treasurer) Dr Daniel Erskine (Secretary) Accountants Orcom Civvals Limited Chartered Accountants 50 Seymour Street London W1H 7JG Bankers Bank of Scotland 174 Byres Road Glasgow G12 8SW COIF Charity Funds CCLA Investment Management Ltd St Alphage House 2 Fare Street London EC2Y 5AQ Principal Address 50 Seymour Street London W1H 7JG 286363
Principal Address Charity Commission Registration Number
THE BRITISH NEUROPATHOLOGICAL SOCIETY
TRUSTEES REPORT
The Trustees present their annual report on the affairs of the Society together with the financial statements and independent examiners report for the year ended 31st December 2025.The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published on 16 July 2014.
Legal & Administrative
The Society is registered as a charity in the United Kingdom, number 286363, and its operations are subject to the Charities Acts 1960 to 2011.
Objects
The object of the Society is to further the study of neuropathology, to promote the exchange of scientific information by means of regular meetings, lectures and demonstrations, and to provide the opportunity for discussions between neuropathologists in Britain and other countries.
The trustees consider that by meeting these objectives they will also meet the Public Benefit test applicable to all Charities.
The financial statements of the Society provide details of major activities undertaken and how the activities have been financed.
The Society has three restricted funds the objects of which are: -
Dorothy Russell and Alfred Meyer Memorial Funds
To provide scientific symposium and lectures in alternate years
NEQAS Fund
To provide quality assurance in relation to neuropathology, to improve and standardise diagnostic neuropathology.
Trustees
The Trustees are listed on page 1.
Organisation
The Society relies, and will continue to rely, on the voluntary work undertaken by the trustees, members of committees and other volunteers. The Society has no employees.
The trustees are elected by the members and, following election, serve a fixed term at the end of which they may stand for reelection if there are no other candidates. Trustees undertake their own training to ensure they achieve their fiduciary duties.
The trustees meet at the Society’s business meetings twice a year at which time strategic decisions are taken.
The trustee and committee meetings are designed to promote and concentrate the educational and scientific value of the Society's activities.
The trustees have a policy to widen representation of the members on committees.
The Society is affiliated to various European bodies but no formal responsibilities to those organisations exist. There are no related parties or subsidiaries.
THE BRITISH NEUROPATHOLOGICAL SOCIETY
TRUSTEES REPORT
Investment Powers
The trustees are permitted to make any investment that they see fit, but in view of the current financial climate consider the best arrangements for surplus funds are with the Charities Investment Fund.
Risk Management
The Trustees regularly review the charity’s activities and consider the opportunities available to the charity to enable it to meet its objectives and the risks to which it is exposed. As part of this process the trustees review the risks which the charity may face, establish systems and procedures to mitigate those risks identified and implement procedures designed to minimise any potential impact on the charity should any of those risks materialise.
The systems are designed to provide reasonable, but not absolute, assurance against material misstatement or loss.
They include regular consideration of financial results, variance from budgets, segregation of duties and the identification and management of risks.
Reserves
The Committee are conscious that in recent years the reserves of the Society have increased to a greater level than would be required to maintain activities even if funding from the journal were to reduce considerably. It is the Trustees intention that unrestricted funds should be reduced to approximately £250,000 over forthcoming years. This will be achieved by an increase number of research grants where suitable projects are proposed and increased academic, training and educational activities. It is also hoped to achieve digitalization and computerisation -online- for society meetings and EQAs, for this a training programme for some members has already begun.
Responsibilities of Trustees
Charity Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the results of the Charity for the period, together with its assets and liabilities at the end of the period and adequately distinguish any material special trust or other restricted fund of the charity. In preparing those financial statements, the Trustees are required to:
Select suitable accounting policies and then apply them consistently;
Make judgements and estimates that are reasonable and prudent;
State whether the policies adopted are in accordance with the appropriate SORP on Accounting by Charities and the Accounting Regulations and with applicable accounting standards, subject to any material departures disclosed and explained in the financial statements; and
Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with applicable Accounting Standards and Statements of Recommended Practice and the regulations made under s44 of the Charities Act 1993. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Dr Silvia Marino BNS President (dated)….............
THE BRITISH NEUROPATHOLOGICAL SOCIETY
INDEPENDENT EXAMINERS REPORT TO THE TRUSTEES
I report on the accounts of the Trust for the year ended 31 December 2025, which are set out on pages 6 to 9.
Respective responsibilities of trustees and examiner
The charity’s trustees are responsible for the preparation of the accounts. The charity's trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the Act) and that an independent examination is needed.
-
examine the accounts under section 145 of the Act;
-
to follow the procedures laid down in the General directions given by the Charity Commissioner
-
under section 145(5)(b) of the Act; and
-
to state whether particular matters have come to my attention.
Basis of independent examiners’ report
My examination was carried out in accordance with the General Directions given by the Charity Commissioners. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and the seeking of explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and, consequently, I do not express an audit opinion on the view given by the accounts.
Independent examiners’ statement
In connection with my examination, no matter has come to my attention:
-
which gives me reasonable cause to believe that, in any material respect, the requirements:
-
to keep accounting records in accordance with s130 of the Act; and
to prepare accounts which accord with the accounting records and to comply with the accounting requirements of the Act
have not been met; or
to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.
M Gibbons FCA Orcom Civvals Limited 50 Seymour St Chartered Accountants London W1H 7JG
8 October 2026
THE BRITISH NEUROPATHOLOGICAL SOCIETY
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31ST DECEMBER 2025
INCOME & EXPENDITURE
| Incoming resources Subscriptions Meeting Income Surplus from Journal Interest receivable Direct charitable Publishing Costs Cost of meetings 3 Grants & sponsorship 4 Subscriptions 5 EQA costs Support expenditure: Committee expenses 6 Website design Administrative costs Bank Charges Accountancy TOTAL EXPENDITURE NET INCOME FOR THE Fund balances brought FUND BALANCES |
Unrestricted Funds £ 10,137 23,824 133,124 10,148 177,233 24,150 234,310 32,315 0 0 290,774 2,747 3,600 6,521 90 6,120 19,078 309,852 (132,619) 670,402 £537,783 |
Restricted Funds £ 4,127 4,127 0 0 0 4,127 51,579 £55,706 |
Total 2025 £ 10,137 23,824 137,251 10,148 181,360 24,150 234,310 32,315 0 0 290,774 2,747 3,600 6,521 90 6,120 19,078 309,852 (128,492) 721,981 £593,489 |
Total 2024 £ 9,671 25,668 136,324 17,389 189,052 8,890 99,932 37,450 5,535 3,047 154,854 815 4,680 200 165 2,940 8,800 163,654 42,050 696,583 £738,633 |
||
|---|---|---|---|---|---|---|
THE BRITISH NEUROPATHOLOGICAL SOCIETY
BALANCE SHEET AS AT 31ST DECEMBER 2025
| 2025 Note £ CURRENT Cash deposits 7 593,489 593,489 LESS: Creditors 8 0 NET CURRENT Total assets less current liabilities Represented by: Unrestricted General Purpose Restricted 2 Dorothy Russell 5,041 Alfred Meyer 44,098 NEQAS Fund 2,788 |
£ 593,489 £593,489 541,562 51,927 £593,489 |
2024 £ 727,861 727,861 5,880 5,054 48,505 -1,980 |
£ 721,981 £721,981 670,402 51,579 £721,981 |
|---|---|---|---|
Approved by the Trustees and signed on their behalf on 22 Oct 2026
Dr Karl Frontzek Treasurer
THE BRITISH NEUROPATHOLOGICAL SOCIETY
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31ST DECEMBER 2025
1. ACCOUNTING POLICIES
(a) These accounts reflect all funds held by the charity, which are governed by the Bye Laws, adopted on 14th July 1977 as amended on 11th January 1991 and 3rd March 2021. The funds held are utilised in accordance with the trusts under which the Trustees are empowered in the Bye Laws.
(b) The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s trust deed, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published on 16 July 2014.
There has been no change to the accounting policies (valuation rules and methods of accounting) since last year.
(c) The accounts have been prepared under the historical cost convention on an accruals basis and include income and expenditure as they are earned or incurred rather than as cash is received or paid, except in the case of the surplus from journal, which is accounted for when received from the publisher.
2. ANALYSIS OF RESTRICTED FUNDS
| Income Subscriptions receivable Interest received Expenditure Lecture costs Laboratory costs Online subscription Net Income For Year Fund Balance Brought FUND BALANCE |
Dorothy Russell Memorial Fund Alfred Meyer Memorial Fund EQA Fund TOTAL £ £ £ 4,127 4,127 442 3,869 641 4,952 442 3,869 4,768 9,079 0 219 6,215 6,434 0 219 6,215 0 6,434 223 (2,346) 4,768 2,645 4,818 46,444 (1,980) 49,282 5,041 44,098 2,788 51,927 |
|---|---|
SH NEUROPATHOLOGICAL SOCIETY
NOTES TO THE ACCOUNTS
YEAR ENDED 31ST DECEMBER 2025
3. MEETINGS Meeting costs
| 2025 £ 234,310 234,310 |
2024 £ 99,932 99,932 |
|---|---|
| 4. GRANTS & Research grants & Sponsorship 5. SUBSCRIPTIONS Euro CNS International Society of 6. TRUSTEES Committee room hire The trustees received no remuneration during the year (2024: nil) 7. CASH DEPOSITS Unrestricted general Unrestricted journal fund Dorothy Russell Memorial NEQAS Restricted fund Alfred Meyer Memorial 8. CREDITORS Creditors |
2025 30,460 1,855 32,315 0 0 2,747 2,747 425,890 115,671 5,042 2,788 44,098 593,489 0 0 |
2024 37,450 0 37,450 5,535 5,535 815 815 568,097 110,930 4,835 1,708 42,291 727,861 5,880 5,880 |
|---|---|---|